Valeo Financial Advisors, LLC Pa Vmed Inc. Transaction History

Valeo Financial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$0.36 - $0.63 $8,280 - $14,490	-23,000 Reduced 6.66%	322,272 $119,000
Q1 2022 Apr 28, 2022	BUY	$1.16 - $2.5 $32,131 - $69,250	27,700 Added 8.72%	345,272 $456,000
Q4 2021 Jan 07, 2022	BUY	$2.46 - $8.74 $24,019 - $85,337	9,764 Added 3.17%	317,572 $781,000
Q3 2021 Nov 02, 2021	BUY	$5.1 - $9.39 $40,692 - $74,922	7,979 Added 2.66%	307,808 $2.63 Million
Q2 2021 Jul 22, 2021	BUY	$3.95 - $6.88 $60,237 - $104,920	15,250 Added 5.36%	299,829 $1.92 Million
Q1 2021 Apr 12, 2021	SELL	$2.01 - $5.55 $95,474 - $263,625	-47,500 Reduced 14.3%	284,579 $1.26 Million
Q4 2020 Feb 11, 2021	BUY	$1.73 - $2.13 $574,496 - $707,328	332,079 New	332,079 $704,000
Q1 2020 Apr 13, 2020	SELL	$1.15 - $3.29 $4,818 - $13,785	-4,190 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$0.84 - $1.2 $2,679 - $3,828	3,190 Added 319.0%	4,190 $5,000
Q2 2019 Jul 10, 2019	BUY	$1.03 - $1.32 $1,030 - $1,320	1,000 New	1,000 $1,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.